BTG3 antibody
Principal name
BTG3 antibody
Alternative names for BTG3 antibody
ANA, TOB5, BTG family member 3, Protein Tob5, Abundant in neuroepithelium area protein
Ncbi ID
NP_001124386, AAH11957, NP_001124386.1, NP_033900.1, NM_009770, NM_019290, NM_006806
Available reactivities
Available hosts
Available applications
Paraffin Sections (P), Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of BTG3 antibody
- Kit Component:
- - KN302308G1, Btg3 gRNA vector 1 in pCas-Guide vector
- KN302308G2, Btg3 gRNA vector 2 in pCas-Guide vector
- KN302308D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
BTG3 Antibody (Center) (Cat. #AP50405PU-N)immunohistochemistry analysis in formalin fixed and paraffin embedded human heart tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of BTG3 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.
BTG3 Antibody (Center) (Cat. #AP50405PU-N) western blot analysis in Hela cell line lysates (35ug/lane).This demonstrates the BTG3 antibody detected the BTG3 protein (arrow).
Predicted cell location: Cytoplasm. Positive control: Human thyroid cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using BTG3 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted band size: 29 kDa . Positive control: Human liver cancer tissue lysate. Recommended dilution: 1/200-1000. (Gel: 10%SDS-PAGE Lysate: 40 ug per lane Primary antibody: 1/100dilution Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution Exposure time: 1 minute)
Predicted cell location: Cytoplasm. Positive control: Human ovarian cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using BTG3 antibody at dilution 1/20, on the right is treated with the fusion protein. (Original magnification:x200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA323848 | BTG3 antibody |
||||||
| Anti-BTG3 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA323849 | BTG3 antibody |
||||||
| Anti-BTG3 Rabbit Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| AP50405PU-N | BTG3 (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| +1 additional image |
|||||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR203216L2V | Lenti ORF particles, Btg3 (GFP-tagged) - Mouse B-cell translocation gene 3 (Btg3), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR203216L1V | Lenti ORF particles, Btg3 (Myc-DDK-tagged) - Mouse B-cell translocation gene 3 (Btg3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR208840L2V | Lenti ORF particles, Btg3 (GFP-tagged ORF) - Rat B-cell translocation gene 3 (Btg3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR208840L1V | Lenti ORF particles, Btg3 (Myc-DDK-tagged ORF) - Rat B-cell translocation gene 3 (Btg3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||